Physician profile
Marjorie M Yong
NPI 1417062167
$2,088.90
in general payments reported to CMS, 2019-2025
9 companies · $723 in 2025
The $723 reported for 2025 was more than what 80% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $40.47 · 2022: $26.05 · 2023: $563 · 2024: $736 · 2025: $723.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,922 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,922.39 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Harmony Biosciences LLC | $1,410.11 | 2022-2025 | Wakix |
| Lilly USA, LLC | $209.79 | 2024-2025 | Zepbound, Mounjaro |
| Abbott Laboratories | $196.89 | 2024 | Pressurewire |
| Corcept Therapeutics | $80.08 | 2025 | Korlym |
| Boehringer Ingelheim Pharmaceuticals, INC. | $66.95 | 2024 | |
| Axsome Therapeutics, INC. | $58.83 | 2025 | Sunosi |
| Inspire Medical Systems, INC. | $25.78 | 2024 | Inspire |
| Philips North America LLC | $21.71 | 2021 | |
| Apria Healthcare LLC | $18.76 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marjorie Yong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.